wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q44778300-586CEAF6-F48B-419B-A1CD-AE1598BDCB2C
Q44778300-586CEAF6-F48B-419B-A1CD-AE1598BDCB2C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q44778300-586CEAF6-F48B-419B-A1CD-AE1598BDCB2C
Low daily dosage of interferon for 1 year after HCV-related end-therapy response. A randomized-controlled study.
P2860
Q44778300-586CEAF6-F48B-419B-A1CD-AE1598BDCB2C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q44778300-586CEAF6-F48B-419B-A1CD-AE1598BDCB2C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
da93738df30da014798f15936346ab13b32d57f0
P2860
Interferon-alpha plus ribavirin for 12 months increases the sustained response rates in chronic hepatitis C relapsers.